Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001913
Filing Date
2024-11-13
Accepted
2024-11-13 06:50:25
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20240930x10q.htm   iXBRL 10-Q 1591179
2 EX-31.1 lptx-20240930xex31d1.htm EX-31.1 14336
3 EX-32.1 lptx-20240930xex32d1.htm EX-32.1 10108
  Complete submission text file 0001410578-24-001913.txt   6287066

Data Files

Seq Description Document Type Size
4 EX-101.SCH lptx-20240930.xsd EX-101.SCH 45732
5 EX-101.CAL lptx-20240930_cal.xml EX-101.CAL 38302
6 EX-101.DEF lptx-20240930_def.xml EX-101.DEF 162917
7 EX-101.LAB lptx-20240930_lab.xml EX-101.LAB 419866
8 EX-101.PRE lptx-20240930_pre.xml EX-101.PRE 289185
63 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20240930x10q_htm.xml XML 974123
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 241451096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)